Cocrystal Pharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Cocrystal Pharma Inc.
- Former names
- Biozone Pharmaceuticals, INC. International Surf Resorts, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Bothell
- Headquarters state / province
- Washington
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- COCP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001412486
- EIN
- 35-2528215
Board of directors
-
Anthony J. Japour · DirectorSince 2023
-
Carol L. Brosgart · DirectorSince 2026
-
Fred Hassan · DirectorSince 2023
-
Phillip Md Et Al Frost · DirectorSince 2023
-
Richard C. Pfenniger Jr. · DirectorSince 2023
-
Roger D. Kornberg · DirectorSince 2023
- Since 2023
Director election results
Annual meeting of June 25, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
88.0%
-
96.4%
-
96.7%
-
97.2%
-
97.6%
-
98.8%
Board connections
6 of this board's directors also sit on 13 other boards.
- via Phillip Md Et Al Frost, Richard C. Pfenniger Jr. and Steven D. Rubin
- via Fred Hassan
- via Steven D. Rubin
- via Steven D. Rubin
- via Carol L. Brosgart
- via Fred Hassan
- via Richard C. Pfenniger Jr.
- via Richard C. Pfenniger Jr.
- via Carol L. Brosgart
- via Steven D. Rubin
- via Fred Hassan
- via Steven D. Rubin
- via Roger D. Kornberg
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $300,631
- 11 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 5, 2026 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +10,000 | $0.98 | $9,816 |
| Aug 3, 2026 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +75,000 | $0.94 | $70,590 |
| Feb 24, 2026 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +20,000 | $1.00 | $20,000 |
| Feb 6, 2026 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +50,000 | $0.95 | $47,500 |
| Dec 31, 2025 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +50,000 | $0.95 | $47,500 |
| Dec 30, 2025 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +20,000 | $0.97 | $19,400 |
| Dec 26, 2025 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +40,000 | $0.97 | $38,800 |
| Dec 24, 2025 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +25,000 | $0.97 | $24,250 |
| Nov 26, 2025 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +1,500 | $1.00 | $1,500 |
| Nov 26, 2025 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +2,500 | $0.99 | $2,475 |
| Nov 25, 2025 | Phillip Md Et Al Frost Director, 10% owner | Open-market purchase | +20,000 | $0.94 | $18,800 |
| Oct 28, 2025 | Phillip Md Et Al Frost Director, 10% owner | Grant or award | +359,713 | $1.39 | $500,001 |
| Oct 28, 2025 | Fred Hassan Director | Grant or award | +359,713 | $1.39 | $500,001 |
| Oct 28, 2025 | Richard C. Pfenniger Jr. Director | Grant or award | +20,000 | — | — |
| Oct 28, 2025 | Martin James Joseph Officer (Co-CEO and CFO) | Grant or award | +3,598 | $1.39 | $5,001 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.